ICON Current Ratio 2010-2025 | ICLR
Current and historical current ratio for ICON (ICLR) from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. ICON current ratio for the three months ending June 30, 2025 was 1.29.
| ICON Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-06-30 | $3.31B | $2.56B | 1.29 |
| 2025-03-31 | $3.42B | $2.69B | 1.27 |
| 2024-12-31 | $3.53B | $2.80B | 1.26 |
| 2024-09-30 | $3.78B | $2.82B | 1.34 |
| 2024-06-30 | $3.60B | $2.74B | 1.31 |
| 2024-03-31 | $3.56B | $2.95B | 1.21 |
| 2023-12-31 | $3.41B | $2.83B | 1.21 |
| 2023-09-30 | $3.42B | $2.87B | 1.19 |
| 2023-06-30 | $3.37B | $2.76B | 1.22 |
| 2023-03-31 | $3.43B | $2.90B | 1.18 |
| 2022-12-31 | $3.23B | $2.69B | 1.20 |
| 2022-09-30 | $3.17B | $2.73B | 1.16 |
| 2022-06-30 | $2.93B | $2.48B | 1.18 |
| 2022-03-31 | $2.87B | $2.54B | 1.13 |
| 2021-12-31 | $2.94B | $2.48B | 1.19 |
| 2021-09-30 | $3.13B | $2.30B | 1.36 |
| 2021-06-30 | $2.29B | $1.11B | 2.07 |
| 2021-03-31 | $2.17B | $1.08B | 2.01 |
| 2020-12-31 | $2.10B | $1.12B | 1.87 |
| 2020-09-30 | $1.77B | $1.24B | 1.43 |
| 2020-06-30 | $1.58B | $1.17B | 1.35 |
| 2020-03-31 | $1.56B | $1.21B | 1.29 |
| 2019-12-31 | $1.63B | $1.13B | 1.44 |
| 2019-09-30 | $1.48B | $0.73B | 2.03 |
| 2019-06-30 | $1.47B | $0.71B | 2.07 |
| 2019-03-31 | $1.44B | $0.71B | 2.02 |
| 2018-12-31 | $1.33B | $0.61B | 2.18 |
| 2018-09-30 | $1.31B | $0.60B | 2.17 |
| 2018-06-30 | $1.15B | $0.55B | 2.10 |
| 2018-03-31 | $1.16B | $0.63B | 1.85 |
| 2017-12-31 | $1.10B | $0.57B | 1.95 |
| 2017-09-30 | $1.00B | $0.53B | 1.90 |
| 2017-06-30 | $1.03B | $0.49B | 2.11 |
| 2017-03-31 | $0.98B | $0.52B | 1.91 |
| 2016-12-31 | $0.96B | $0.49B | 1.94 |
| 2016-09-30 | $1.01B | $0.46B | 2.20 |
| 2016-06-30 | $0.91B | $0.46B | 1.99 |
| 2016-03-31 | $0.94B | $0.57B | 1.66 |
| 2015-12-31 | $0.86B | $0.57B | 1.51 |
| 2015-09-30 | $1.02B | $0.91B | 1.12 |
| 2015-06-30 | $0.83B | $0.57B | 1.46 |
| 2015-03-31 | $0.81B | $0.56B | 1.45 |
| 2014-12-31 | $0.82B | $0.54B | 1.52 |
| 2014-09-30 | $0.86B | $0.54B | 1.60 |
| 2014-06-30 | $0.80B | $0.50B | 1.59 |
| 2014-03-31 | $0.91B | $0.50B | 1.81 |
| 2013-12-31 | $0.85B | $0.50B | 1.70 |
| 2013-09-30 | $0.78B | $0.48B | 1.63 |
| 2013-06-30 | $0.71B | $0.46B | 1.56 |
| 2013-03-31 | $0.66B | $0.43B | 1.53 |
| 2012-12-31 | $0.66B | $0.41B | 1.61 |
| 2012-09-30 | $0.59B | $0.38B | 1.54 |
| 2012-06-30 | $0.57B | $0.37B | 1.53 |
| 2012-03-31 | $0.57B | $0.37B | 1.54 |
| 2011-12-31 | $0.56B | $0.31B | 1.83 |
| 2011-09-30 | $0.57B | $0.29B | 1.95 |
| 2011-06-30 | $0.60B | $0.27B | 2.20 |
| 2011-03-31 | $0.60B | $0.29B | 2.05 |
| 2010-12-31 | $0.58B | $0.25B | 2.32 |
| 2010-09-30 | $0.57B | $0.26B | 2.17 |
| 2010-06-30 | $0.53B | $0.25B | 2.13 |
| 2010-03-31 | $0.54B | $0.28B | 1.95 |
| 2009-12-31 | $0.54B | $0.30B | 1.79 |
| 2009-09-30 | $0.54B | $0.32B | 1.68 |
| 2009-06-30 | $0.52B | $0.33B | 1.61 |
| 2009-03-31 | $0.49B | $0.28B | 1.74 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $14.370B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.378B | 27.33 |
| CVS Health (CVS) | United States | $92.778B | 11.54 |
| Elevance Health (ELV) | United States | $71.753B | 9.65 |
| Cencora (COR) | United States | $56.537B | 18.83 |
| DiDi Global (DIDIY) | China | $27.533B | 22.50 |
| Labcorp Holdings (LH) | United States | $23.101B | 18.36 |
| Natera (NTRA) | United States | $23.092B | 0.00 |
| BioMerieux (BMXMF) | France | $16.600B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.580B | 0.00 |
| Medpace Holdings (MEDP) | United States | $13.359B | 35.35 |
| CochLear (CHEOY) | Australia | $12.878B | 0.00 |
| Solventum (SOLV) | United States | $12.673B | 13.08 |
| Viatris (VTRS) | United States | $12.300B | 4.38 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.796B | 0.00 |
| Revvity (RVTY) | United States | $10.459B | 18.43 |
| Avantor (AVTR) | United States | $9.183B | 13.47 |
| Charles River Laboratories (CRL) | United States | $8.037B | 15.25 |
| Sonic Healthcare (SKHHY) | Australia | $7.750B | 0.00 |
| HealthEquity (HQY) | United States | $7.725B | 33.84 |
| Bausch + Lomb (BLCO) | Canada | $5.179B | 34.83 |
| Sotera Health (SHC) | United States | $4.650B | 25.98 |
| BrightSpring Health Services (BTSG) | United States | $4.197B | 32.01 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.82 |
| GeneDx Holdings (WGS) | United States | $3.720B | 85.19 |
| Alignment Healthcare (ALHC) | United States | $3.240B | 0.00 |
| Concentras Parent (CON) | United States | $3.050B | 19.35 |
| Surgery Partners (SGRY) | United States | $2.909B | 36.60 |
| Organon (OGN) | United States | $2.449B | 2.67 |
| Premier (PINC) | United States | $2.138B | 19.77 |
| KindlyMD (NAKA) | United States | $2.046B | 0.00 |
| Progyny (PGNY) | United States | $2.035B | 43.04 |
| Ardent Health (ARDT) | United States | $1.816B | 7.01 |
| PACS (PACS) | United States | $1.774B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.511B | 25.59 |
| Pediatrix Medical (MD) | United States | $1.499B | 10.01 |
| Teladoc Health (TDOC) | United States | $1.366B | 0.00 |
| Omada Health (OMDA) | $1.364B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.196B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.847B | 4.96 |
| AMN Healthcare Services Inc (AMN) | United States | $0.796B | 9.85 |
| CareDx (CDNA) | United States | $0.727B | 13.39 |
| Performant Healthcare (PHLT) | United States | $0.603B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 100.00 |
| Agilon Health (AGL) | United States | $0.530B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.517B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.488B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 6.99 |
| Nutex Health (NUTX) | United States | $0.465B | 7.05 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.424B | 0.00 |
| SBC Medicals (SBC) | United States | $0.424B | 9.27 |
| Enhabit (EHAB) | United States | $0.399B | 26.27 |
| So-Young (SY) | China | $0.390B | 0.00 |
| Oncology Institute (TOI) | United States | $0.318B | 0.00 |
| LifeMD (LFMD) | United States | $0.294B | 0.00 |
| Beauty Health (SKIN) | United States | $0.264B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.226B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.173B | 0.00 |
| DocGo (DCGO) | United States | $0.153B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.122B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.066B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.017B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.005B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |